BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $566,566 (93.4% shares, 6.6% debt)

Holdings (30)

— ARRAY BIOPHARMA INC 11.7%

Value ($000) $66,110 Shares 9,169,276 Est. Cost $4.56 Unrealized —

— CHEMOCENTRYX INC 10.6%

Value ($000) $59,832 Shares 7,270,013 Est. Cost $10.60 Unrealized —

— BLUEPRINT MEDICINES CORP 7.4%

Value ($000) $41,918 Shares 1,582,408 Est. Cost $26.49 Unrealized —

— FORWARD PHARMA A/S 6.8%

Value ($000) $38,392 Shares 1,008,981 Est. Cost $21.63 Unrealized —

— CONCERT PHARMACEUTICALS INC 6.6%

Value ($000) $37,544 Shares 2,521,452 Est. Cost $13.81 Unrealized —

— ONCOTHYREON INC 6.4%

Value ($000) $36,481 Shares 9,754,178 Est. Cost $1.78 Unrealized —

— EXELIXIS INC 6.0%

Value ($000) $34,009 Shares 38,239,000 Est. Cost $0.81 Unrealized —

— LOXO ONCOLOGY INC 5.1%

Value ($000) $29,120 Shares 1,615,081 Est. Cost $14.62 Unrealized —

— ONCOMED PHARMACEUTICALS INC 5.0%

Value ($000) $28,456 Shares 1,264,715 Est. Cost $22.40 Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 4.6%

Value ($000) $26,184 Shares 2,171,108 Est. Cost $10.93 Unrealized +6.3%

— VITAE PHARMACEUTICALS INC 4.1%

Value ($000) $23,106 Shares 1,604,615 Est. Cost $10.33 Unrealized —

— TOBIRA THERAPEUTICS INC 3.6%

Value ($000) $20,273 Shares 1,175,233 Est. Cost $17.25 Unrealized —

— TARGACEPT INC 3.3%

Value ($000) $18,568 Shares 6,655,128 Est. Cost $4.29 Unrealized —

— GTX INC DEL 2.8%

Value ($000) $15,835 Shares 10,772,306 Est. Cost $0.73 Unrealized —

— QLT INC 2.7%

Value ($000) $15,436 Shares 3,737,446 Est. Cost $4.17 Unrealized —

CYTK CYTOKINETICS INC 2.5%

Value ($000) $14,159 Shares 2,106,989 Est. Cost $5.41 Unrealized +21.2%

EXEL EXELIXIS INC 1.8%

Value ($000) $10,401 Shares 2,766,152 Est. Cost $1.68 Unrealized +93.6%

— ARQULE INC 1.8%

Value ($000) $10,289 Shares 6,430,708 Est. Cost $1.90 Unrealized —

— SEATTLE GENETICS INC 1.7%

Value ($000) $9,680 Shares 200,000 Est. Cost $48.40 Unrealized —

XENE XENON PHARMACEUTICALS INC 1.4%

Value ($000) $7,826 Shares 678,764 Est. Cost $14.32 Unrealized -3.4%

— FIVE PRIME THERAPEUTICS INC 1.1%

Value ($000) $5,976 Shares 240,597 Est. Cost $17.29 Unrealized —

— ARRAY BIOPHARMA INC 0.6%

Value ($000) $3,169 Shares 2,500,000 Est. Cost $1.27 Unrealized —

— CATABASIS PHARMACEUTICALS IN 0.5%

Value ($000) $2,747 Shares 225,000 Est. Cost $12.21 Unrealized —

— MAST THERAPEUTICS INC 0.4%

Value ($000) $2,505 Shares 5,111,293 Est. Cost $0.56 Unrealized —

— ATYR PHARMA INC 0.4%

Value ($000) $2,495 Shares 134,725 Est. Cost $18.52 Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.4%

Value ($000) $2,377 Shares 1,020,108 Est. Cost $2.99 Unrealized —

GBIM GLOBEIMMUNE INC 0.3%

Value ($000) $1,771 Shares 678,400 Est. Cost $6.22 Unrealized 0.0%

— BIOTA PHARMACEUTIALS INC 0.1%

Value ($000) $726 Shares 350,776 Est. Cost $6.11 Unrealized —

— ACHAOGEN INC 0.1%

Value ($000) $643 Shares 106,700 Est. Cost $14.91 Unrealized —

— APTOSE BIOSCIENCES INC 0.1%

Value ($000) $538 Shares 105,429 Est. Cost $5.92 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARRAY BIOPHARMA INC	9,169,276	$66,110	11.7%	$4.56	—	COM	04269X105
—	CHEMOCENTRYX INC	7,270,013	$59,832	10.6%	$10.60	—	COM	16383L106
—	BLUEPRINT MEDICINES CORP	1,582,408	$41,918	7.4%	$26.49	—	COM	09627Y109
—	FORWARD PHARMA A/S	1,008,981	$38,392	6.8%	$21.63	—	SPONSORED ADR	34986J105
—	CONCERT PHARMACEUTICALS INC	2,521,452	$37,544	6.6%	$13.81	—	COM	206022105
—	ONCOTHYREON INC	9,754,178	$36,481	6.4%	$1.78	—	COM	682324108
—	EXELIXIS INC	38,239,000	$34,009	6.0%	$0.81	—	NOTE 4.250% 8/1	30161QAC8
—	LOXO ONCOLOGY INC	1,615,081	$29,120	5.1%	$14.62	—	COM	548862101
—	ONCOMED PHARMACEUTICALS INC	1,264,715	$28,456	5.0%	$22.40	—	COM	68234X102
IRWD	IRONWOOD PHARMACEUTICALS INC	2,171,108	$26,184	4.6%	$10.93	+6.3%	COM CL A	46333X108
—	VITAE PHARMACEUTICALS INC	1,604,615	$23,106	4.1%	$10.33	—	COM	92847N103
—	TOBIRA THERAPEUTICS INC	1,175,233	$20,273	3.6%	$17.25	—	COM	88883P101
—	TARGACEPT INC	6,655,128	$18,568	3.3%	$4.29	—	COM	87611R306
—	GTX INC DEL	10,772,306	$15,835	2.8%	$0.73	—	COM	40052B108
—	QLT INC	3,737,446	$15,436	2.7%	$4.17	—	COM	746927102
CYTK	CYTOKINETICS INC	2,106,989	$14,159	2.5%	$5.41	+21.2%	COM NEW	23282W605
EXEL	EXELIXIS INC	2,766,152	$10,401	1.8%	$1.68	+93.6%	COM	30161Q104
—	ARQULE INC	6,430,708	$10,289	1.8%	$1.90	—	COM	04269E107
—	SEATTLE GENETICS INC	200,000	$9,680	1.7%	$48.40	—	COM	812578102
XENE	XENON PHARMACEUTICALS INC	678,764	$7,826	1.4%	$14.32	-3.4%	COM	98420N105
—	FIVE PRIME THERAPEUTICS INC	240,597	$5,976	1.1%	$17.29	—	COM	33830X104
—	ARRAY BIOPHARMA INC	2,500,000	$3,169	0.6%	$1.27	—	NOTE 3.000% 6/0	04269XAA3
—	CATABASIS PHARMACEUTICALS IN	225,000	$2,747	0.5%	$12.21	—	COM	14875P107
—	MAST THERAPEUTICS INC	5,111,293	$2,505	0.4%	$0.56	—	COM	576314108
—	ATYR PHARMA INC	134,725	$2,495	0.4%	$18.52	—	COM	002120103
—	ONCOGENEX PHARMACEUTICALS IN	1,020,108	$2,377	0.4%	$2.99	—	COM	68230A106
GBIM	GLOBEIMMUNE INC	678,400	$1,771	0.3%	$6.22	0.0%	COM	37957B100
—	BIOTA PHARMACEUTIALS INC	350,776	$726	0.1%	$6.11	—	COM	090694100
—	ACHAOGEN INC	106,700	$643	0.1%	$14.91	—	COM	004449104
—	APTOSE BIOSCIENCES INC	105,429	$538	0.1%	$5.92	—	COM NEW	03835T200